Janku Filip 4
4 · Monte Rosa Therapeutics, Inc. · Filed Jun 25, 2021
Insider Transaction Report
Form 4
Janku Filip
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-06-23+387,069→ 387,069 totalExercise: $19.00Exp: 2031-06-22→ Common Stock (387,069 underlying)
Footnotes (1)
- [F1]25% of this option shall vest and become exercisable on June 1, 2022, with the remainder vesting in 36 substantially equal monthly installments thereafter.